COMMUNIQUÉS West-GlobeNewswire

FDA Grants Fast Track Designation to SOTIO’s SOT106 ADC for Soft Tissue Sarcoma Treatment, Accelerating Clinical Development
26/08/2026
SOT106 targets LRRC15, a clinically validated target broadly expressed across multiple sarcoma subtypes First-in-human study expected to begin this year, marking a key development milestone for SOT106 PRAGUE, Basel and [...]
BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy
26/08/2026
Initial phase study marks the clinical evaluation of the Abreu BTT 700 TMS and its thermofebrile protocol, laying the foundation for future efficacy trials in the treatment of ALS and other neurodegenerative disorders [...]
Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
26/08/2026
New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities Blair, Nebraska, Aug. 26, 2026 (GLOBE NEWSWIRE) -- As the U.S. biotechnology sector [...]
CoreHealth Technologies Acquires Konnected to Expand Wellness Expertise and Program Delivery Capabilities
26/08/2026
TORONTO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- CoreHealth Technologies, a leading provider of configurable wellness technology and health assessment solutions, today announced the acquisition of Konnected Workplace Wellness [...]
Curonix LLC Appoints Healthcare and Financial Services Veteran Carlos A. Migoya to Board of Managers
26/08/2026
POMPANO BEACH, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the appointment of Carlos A. Migoya to its Board of Managers [...]
NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
26/08/2026
NAARDEN, The Netherlands and MIAMI, Aug. 26, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
26/08/2026
RADNOR, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Tvardi Therapeutics to Participate in Upcoming Investor Events
26/08/2026
HOUSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting [...]
Guidelight Health Virtual Brings Evidence-Based Mental Health Care to All of Colorado, Massachusetts and North Carolina
26/08/2026
Expansion means clients no longer need to live near a Guidelight clinic to access the same structured, skills-based care BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Guidelight Health, a leader in evidence-based mental [...]
SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth
26/08/2026
National nine-city education series expands Hydrafacial's industry-leading provider training platform LONG BEACH, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (NASDAQ: SKIN), home to Hydrafacial, today [...]
InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference
26/08/2026
DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible [...]
Candel Therapeutics to Present at September Investor Conferences
26/08/2026
NEEDHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
26/08/2026
Leading oncology experts and company management will discuss the Phase 3 OVATION 3 study, supporting science and data, clinical progress, and upcoming milestones A patient treated with IMNN-001 will share firsthand [...]
NOMAD Power Solutions, Inc. Receives DOE Authorization to Advance Vermont Long-Duration Energy Storage Project into Phase 3
26/08/2026
Installation phase will deploy NOMAD’s transportable battery energy storage technology at sites within Green Mountain Power’s service territory BOCA RATON, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, [...]
Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
26/08/2026
If approved, REVTORPYK would be the first and only therapy for advanced breast cancer with a PIK3CA mutation that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 MINNEAPOLIS, Aug. 26 [...]
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
26/08/2026
New patent broadens protection around systems integrating real-time physiological feedback, sensing and imaging with controlled therapeutic delivery, including neural ablation approaches for cancer pain THE WOODLANDS, [...]
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
26/08/2026
CEO Jonathan Cohen to Detail the Company’s Strongest Quarterly Performance Since Commercial Launch of Multi-Cancer Early Detection Testing, Key Takeaways from the Next Generation Dx Summit, and Path to Broader [...]
SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
26/08/2026
The addition of leading AI researcher further strengthens SciSparc’s scientific and technical foundation as the Company advances its strategic focus on the Agentic AI market TEL AVIV, Israel, Aug. 26, 2026 (GLOBE [...]
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
26/08/2026
Cumulative Personal Investment by Leadership Since November 2025 Reaches Approximately $3.75 Million NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a [...]

Pages